Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-27

FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for Enalapril Maleate and Hydrochlorothiazide (a fixed-dose combination) by Taro Pharmaceuticals U.S.A., Inc., enabling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril Maleate and Hydrochlorothiazide (enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)